We are live on ! Find out more
VIVS

VivoSim Labs

29 hedge funds and large institutions have $644K invested in VivoSim Labs in 2025 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

241% more capital invested

Capital invested by funds: $189K → $644K (+$455K)

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

12% more funds holding

Funds holding: 2629 (+3)

3.55% more ownership

Funds ownership: 4.95%8.49% (+3.5%)

Holders
29
Holders Change
+3
Holders Change %
+11.54%
% of All Funds
0.38%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
6
Reduced
4
Closed
8
Calls
Puts
Net Calls
Net Calls Change

VIVS Hedge Fund Activity: Q3 2025 in Review

29 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q3 2025, worth a combined $644K — up 241% from $189K a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new VIVS positions and 8 closed out — a net gain of 3 holders — while 6 added to existing stakes and 4 trimmed.

The largest buyer was DRW Securities, opening a new position worth an estimated $160K. The largest seller was Citadel Advisors, exiting entirely with an estimated $84.5K sold.

  • 29 institutional investors held VivoSim Labs (VIVS) as of Q3 2025, up from 26 in Q2 2025.
  • Funds reported $644K of VivoSim Labs stock for Q3 2025, up 241% quarter-over-quarter.
  • 11 funds opened new VivoSim Labs positions in Q3 2025 and 8 closed out, a net change of +3 holders.
  • The largest VivoSim Labs buyer in Q3 2025 was DRW Securities, an estimated $160K added.
  • The largest VivoSim Labs seller in Q3 2025 was Citadel Advisors, an estimated $84.5K sold.

Based on aggregated 13F filings for Q3 2025.